Balneotherapy — The Science of Therapeutic Bathing

The word balneotherapy comes from the Latin balneum — bath. It describes the use of mineral waters, thermal springs, or natural preparations such as peat mud for therapeutic purposes. It is one of the oldest organized medical practices in the world, and it has attracted more rigorous scientific scrutiny than its reputation might suggest.

This article covers what balneotherapy actually is, how it differs from plain thermal bathing or hydrotherapy, and what the evidence shows for specific conditions.

Balneotherapy vs Hydrotherapy — An Important Distinction

These terms are often used interchangeably, but they describe different things.

Hydrotherapy uses water itself as the therapeutic medium — temperature, pressure, buoyancy. The water is typically clean, mineral-free, and the therapeutic effects are physical: reduced joint loading, improved circulation, muscle relaxation.

Balneotherapy uses waters or preparations with specific chemical content — mineral springs, thermal waters, peat mud, or CO₂-enriched water. The therapeutic effects are both physical and chemical. The minerals, humic substances, and other compounds in the medium are absorbed through the skin and exert biological effects independent of heat.

The distinction matters because controlled studies have compared peat baths to plain hot water baths at the same temperature. Peat baths consistently produce superior outcomes — not because the heat is different, but because the chemical fraction adds a separate mechanism of action.

The Dual Mechanism of Peat Balneotherapy

Peat baths work through two simultaneous pathways.

Thermal pathway. Peat has exceptional thermal retention — it loses less than 1°C over 20 minutes (Korhonen 2008), compared to water which cools much faster. Sustained heat at 38–42°C causes vasodilation, increasing blood flow to muscles and joints. Peripheral vasodilation activates the heat shock protein response, which has downstream anti-inflammatory effects. Heat also raises the pain threshold by affecting thermoreceptors and nociceptors.

Chemical pathway. Humic acids, fulvic acids, and other peat-derived compounds penetrate the skin during immersion (Beer et al. 2003). Once absorbed, they act directly on tissues: inhibiting pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), chelating minerals for transdermal delivery, exerting antioxidant effects, and modulating immune cell activity. This chemical pathway continues to act after the bath ends, as absorbed compounds remain in tissue for hours.

The two pathways reinforce each other: heat enhances skin permeability, increasing absorption of the chemical fraction. And anti-inflammatory chemical effects reduce the inflammation that would otherwise limit the benefit of heat therapy.

A Standard Course of Treatment

Clinical balneotherapy is not a one-off experience. The evidence base relates to structured courses:

• Temperature: 38–42°C (higher than typical hot baths; lower temperatures show reduced clinical effect)
• Duration: 15–30 minutes per session
• Frequency: Daily or every other day
• Course length: 10–21 sessions over 2–3 weeks
• Rest period: 30–60 minutes of horizontal rest after each session is standard practice in spa clinics and is considered clinically significant, not optional

A course of 21 daily peat baths represents a cumulative exposure to bioactive compounds that no single session can replicate. The evidence for psoriasis, for example, refers specifically to 2–3 week courses — not single applications.

What the Evidence Shows by Condition

Joint conditions — strongest evidence. The evidence base for balneotherapy in musculoskeletal conditions is the most robust of any indication. Karagulle and Karagulle (2007) conducted a randomized controlled trial of peloid therapy for knee osteoarthritis showing significant WOMAC (Western Ontario and McMaster Universities Arthritis Index) improvements. Tefner et al. (2013) published a double-blind RCT (n=53) using Neydharting mud packs in which medication use decreased significantly in the mud group but not the control group. Bender et al. (2013) produced a meta-analysis confirming strong evidence for Hungarian balneotherapy in musculoskeletal conditions. Keilani et al. (2025) synthesized 13 RCTs and quasi-RCTs from 2019–2025, all confirming balneotherapy efficacy for osteoarthritis.

Low back pain — moderate evidence. Crevenna et al. (2025) conducted a systematic review of balneotherapy for chronic low back pain covering the past five years, finding positive outcomes across multiple controlled studies.

Psoriasis — moderate evidence. Jazani et al. (2022) published a systematic review confirming balneotherapy efficacy for psoriasis, drawing on cohort studies from Czech, Hungarian, and German spa clinics. Most studies report PASI score improvements after 2–3 week treatment courses. Evidence is limited by the difficulty of blinding in balneotherapy trials.

Atopic dermatitis (eczema) — preliminary evidence. Clinical observations from peloid therapy studies include improvement in eczema symptoms. Mechanistic support is strong — fulvic acids specifically attenuate atopic dermatitis pathways by downregulating CCL17 and CCL22 via p38 MAPK and JNK inhibition (Wu et al. 2023) — but large-scale clinical trials in eczema specifically are lacking.

Gynecological conditions — historical evidence. Peat therapy for dysmenorrhea, chronic pelvic pain, and adnexal inflammation was the primary indication in 19th and early 20th century European spa medicine. This evidence base is older and methodologically weaker by modern standards, but clinical use in this area continues in Czech and German spa clinics.

Where Balneotherapy Is Practiced

Balneotherapy exists primarily in dedicated spa clinic environments:

• Czech Republic — Třeboň and Františkovy Lázně are the best-known peat balneotherapy centers, with active clinical programs
• Germany — Bad Aibling, Bad Kohlgrub; peat baths historically covered by statutory health insurance (Moortherapie)
• Hungary — Lake Hévíz offers unique thermal-peat therapy (naturally warm peat lake)
• Estonia — Pärnu and Võsu; peat balneotherapy part of the local health tourism offer
• Austria — Neydharting; Neydharting Moor is the substrate used in several clinical trials

Home use is possible with peat bath additives and concentrated peat extracts, but full immersion and clinical-grade concentrations are not replicable at home. The evidence base relates to clinical settings.

An Honest Assessment

Balneotherapy is not fringe medicine in Central Europe. It is integrated into healthcare systems that have applied clinical scrutiny to its effects for over a century. The evidence for musculoskeletal conditions is now strong enough to satisfy modern systematic review standards. The dermatological evidence is more limited but mechanistically coherent.

The main gaps are funding and methodology. Balneotherapy is difficult to subject to the double-blind RCT design that is the gold standard for drug trials — you cannot easily blind a patient to whether they are in a peat bath or plain water. Industry funding incentives favor pharmaceutical research. These are structural problems with the evidence base, not evidence of inefficacy.

What can be said with confidence: peat balneotherapy is not equivalent to a hot bath. The chemical fraction is real, absorbed, and biologically active. The clinical improvements reported in the literature are consistent across different countries, different peat types, and different research groups.